All Research

Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD

New England Journal of Medicine·
Read the paperDOI: 10.1056/NEJMoa2501396

TL;DR

A new eye implant called the PRIMA system helped restore central vision in people with geographic atrophy, a severe form of age-related macular degeneration that causes blindness. After 12 months, patients showed significant improvement in their ability to see, offering hope for treating a condition that currently has no cure.

In this study involving 38 participants with geographic atrophy due to AMD, the PRIMA system restored central vision and led to a significant improvement in visual acuity from baseline to month 12. (Funded by Science Corporation and the Moorfields National Institute for Health and Care Research Biomedical Research Centre; PRIMAvera ClinicalTrials.gov number, NCT04676854.).

  • 1The PRIMA system is a subretinal photovoltaic implant that can restore central vision in patients with geographic atrophy
  • 238 participants with geographic atrophy due to AMD were included in the clinical trial
  • 3Visual acuity improved significantly from baseline measurements to 12 months after implantation
  • 4The study was funded by Science Corporation and registered as a clinical trial (NCT04676854)
Nature Neuroscience·

Adversarial AI reveals mechanisms and treatments for disorders of consciousness

Imagine your brain is like a city with millions of roads and traffic systems. When you're awake and conscious, traffic flows in complex, coordinated patterns. In a coma, something has gone wrong — but we've never had a great way to figure out exactly which roads are broken or how to fix them. This study built a very smart AI that learned to tell the difference between 'awake brain' and 'coma brain' by studying hundreds of thousands of brainwave recordings. Then, like a detective, the AI was pitted against a simulated model of the brain to figure out: what changes in the brain's wiring would explain the difference? The AI figured out — on its own, without being told — that two key things go wrong in a coma: a specific circuit deep in the brain (called the basal ganglia indirect pathway) gets disrupted, and the brain's 'braking system' (inhibitory neurons) starts working too hard in the wrong places. The researchers then checked these predictions against real patient data, and both checked out. The AI also suggested that zapping a specific deep brain region with high-frequency electrical pulses might help wake people up — and early evidence from human patients supports this idea.

Disorders of consciousness
Artificial Intelligence
Nature·

Gene conversion empowers natural selection in a clonal fish species

Unfortunately, the content of this research abstract could not be accessed due to paywall restrictions. Without being able to read the actual findings about gene conversion in clonal fish species, I cannot provide an accurate explanation of what the researchers discovered or why it matters.

Science Advances·

Direct detection of an asteroid’s heliocentric deflection: The Didymos system after DART

NASA crashed a spacecraft into an asteroid moon called Dimorphos in 2022, and scientists have now measured that this impact actually nudged the entire asteroid system slightly off its path around the Sun. This is the first time humans have measurably changed how a celestial body orbits the Sun, proving that we can potentially deflect dangerous asteroids heading toward Earth.

Nature Astronomy·

The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression

Think of your brain as having billions of tiny locks and keys. One particular lock — called the AMPA receptor — sits on brain cells and helps them talk to each other using the chemical glutamate. In people with hard-to-treat depression, this study found that those locks are less plentiful than normal, especially in emotional brain regions. When doctors gave these patients ketamine, it actually changed how many of those locks were available on the cell surface — and the bigger that change was, the better the patient felt. So ketamine isn't just temporarily numbing pain; it appears to be physically restoring a broken communication system in the brain. The scientists confirmed this by using a special brain scan (PET scan) with a radioactive tracer that literally glows where those AMPA receptor locks are located, letting them count them in real time in living people.

treatment-resistant depression
ketamine